Author Index

Search or browse for an author across our entire electronic archive

Search results for: D
Results 921 - 930 of 1338 shown below

  • Donnini, S

    L Morbidelli, S Donnini, S Filippi, L Messori, F Piccioli, P Orioli, G Sava and M Ziche

    Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers

    doi:10.1038/sj.bjc.6600906

  • Dono, K

    H Ota, H Nagano, M Sakon, H Eguchi, M Kondo, T Yamamoto, M Nakamura, B Damdinsuren, H Wada, S Marubashi, A Miyamoto, K Dono, K Umeshita, S Nakamori, K Wakasa and M Monden

    Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression

    advance online publication, 2005-08-16 00:00:00.000;

    doi:10.1038/sj.bjc.6602742

  • T Noda, H Nagano, I Takemasa, S Yoshioka, M Murakami, H Wada, S Kobayashi, S Marubashi, Y Takeda, K Dono, K Umeshita, N Matsuura, K Matsubara, Y Doki, M Mori and M Monden

    Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma

    advance online publication, 2009-04-28 00:00:00.000;

    doi:10.1038/sj.bjc.6605064

  • Y Ito, N Matsuura, M Sakon, T Takeda, K Umeshita, H Nagano, S Nakamori, K Dono, M Tsujimoto, M Nakahara, K Nakao and M Monden

    Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma

    doi:10.1038/sj.bjc.6690758

  • Y Ito, M Monden, T Takeda, H Eguchi, K Umeshita, H Nagano, S Nakamori, K Dono, M Sakon, M Nakamura, M Tsujimoto, M Nakahara, K Nakao, Y Yokosaki and N Matsuura

    The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma

    doi:10.1054/bjoc.1999.1065

  • Dono, M

    G Cutrona, P Tasso, M Dono, S Roncella, M Ulivi, E M Carpaneto, V Fontana, M Comis, F Morabito, M Spinelli, E Frascella, L C Boffa, G Basso, V Pistoia and M Ferrarini

    CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL

    doi:10.1038/sj.bjc.6600329

  • Donovan, J

    Z Kote-Jarai, S Jugurnauth, S Mulholland, D A Leongamornlert, M Guy, S Edwards, M Tymrakiewitcz, L O'Brien, A Hall, R Wilkinson, A A Al Olama, J Morrison, K Muir, D Neal, J Donovan, F Hamdy, D F Easton and R Eeles

    A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer

    advance online publication, 2009-01-06 00:00:00.000;

    doi:10.1038/sj.bjc.6604847

  • N Pashayan, S W Duffy, P Pharoah, D Greenberg, J Donovan, R M Martin, F Hamdy and D E Neal

    Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening

    advance online publication, 2009-03-17 00:00:00.000;

    doi:10.1038/sj.bjc.6604973

  • Donovan, J L

    D Gunnell, S E Oliver, T J Peters, J L Donovan, R Persad, M Maynard, D Gillatt, A Pearce, F C Hamdy, D E Neal and J M P Holly

    Are diet–prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men

    doi:10.1038/sj.bjc.6600946

  • C Metcalfe, J A Lane, F Hamdy, D Neal and J L Donovan

    A model of the natural history of screen-detected prostate cancer

    advance online publication, 2006-09-26 00:00:00.000;

    doi:10.1038/sj.bjc.6603368

  • Donovan, M

    M J Smith, A C Culhane, M Donovan, J C Coffey, B D Barry, M A Kelly, D G Higgins, J H Wang, W O Kirwan, T G Cotter and H P Redmond

    Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purification

    doi:10.1038/sj.bjc.6604931

  • Donskov, F

    F Donskov, K M Bennedsgaard, H von der Maase, N Marcussen, R Fisker, J J Jensen, P Naredi and M Hokland

    Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival

    doi:10.1038/sj.bjc.6600437

  • F Donskov, N Marcussen, M Hokland, R Fisker, H H T Madsen and H von der Maase

    In vivo assessment of the antiproliferative properties of interferon-alpha during immunotherapy: Ki-67 (MIB-1) in patients with metastatic renal cell carcinoma

    doi:10.1038/sj.bjc.6601587

  • F Donskov, M Middleton, K Fode, P Meldgaard, W Mansoor, J Lawrance, N Thatcher, H Nellemann and H von der Maase

    Two randomised phase II trials of subcutaneous interleukin-2 and histamine dihydrochloride in patients with metastatic renal cell carcinoma

    advance online publication, 2005-08-30 00:00:00.000;

    doi:10.1038/sj.bjc.6602768

  • F Donskov, M Hokland, N Marcussen, H H Torp Madsen and H von der Maase

    Monocytes and neutrophils as 'bad guys' for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma – results from a randomised phase II trial

    doi:10.1038/sj.bjc.6602937

  • Doody, M M

    K J Johnson, B H Alexander, M M Doody, A J Sigurdson, M S Linet, L G Spector, R W Hoffbeck, S L Simon, R M Weinstock and J A Ross

    Childhood cancer in the offspring born in 1921–1984 to US radiologic technologists

    advance online publication, 2008-07-29 00:00:00.000;

    doi:10.1038/sj.bjc.6604516

  • Doolan, P

    S Kennedy, M Clynes, P Doolan, J P Mehta, S Rani, J Crown and L O'Driscoll

    SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in breast cancer and is not expressed in normal breast tissue

    advance online publication, 2008-05-13 00:00:00.000;

    doi:10.1038/sj.bjc.6604365

  • Dooley, M J

    M J Dooley, S Singh and D Rischin

    Rounding of low serum creatinine levels and consequent impact on accuracy of bedside estimates of renal function in cancer patients

    doi:10.1038/sj.bjc.6601641

  • L J Worth, M J Dooley, J F Seymour, L Mileshkin, M A Slavin and K A Thursky

    An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital

    advance online publication, 2005-02-22 00:00:00.000;

    doi:10.1038/sj.bjc.6602412